Latest news
William Blair Maintains VistaGen Therapeutics(VTGN.US) With Hold Rating - MoomooMoomoo · Thu, 06 Aug 2026 19:50:30 GMTVistagen (VTGN) Reports Phase 2 Social Anxiety Study Results Ami - GuruFocusGuruFocus · Thu, 06 Aug 2026 15:59:51 GMTVistagen's second fasedienol dose showed no new safety findings - Stock TitanStock Titan · Thu, 06 Aug 2026 12:30:00 GMTVistagen Therapeutics (NASDAQ: VTGN) granted 180-day Nasdaq bid-price extension - Stock TitanStock Titan · Wed, 05 Aug 2026 20:05:55 GMTSRX Global (NYSE American: SRXH) Acquires Stake in Vistagen Therapeutics - TradingViewTradingView · Tue, 04 Aug 2026 17:49:58 GMTVistagen Therapeutics, Inc. Stockholders with Large Losses in VTG - The National Law ReviewThe National Law Review · Tue, 04 Aug 2026 17:23:17 GMTVTGN Q2 2026 Earnings: EPS Miss of -$0.37 Highlights Continued Investment in Pre-Revenue Pipeline - dars.gov.etdars.gov.et · Mon, 03 Aug 2026 02:47:10 GMTVTGN Aug 2026 7.000 put (VTGN260821P00007000) stock price, news, quote and history - Yahoo Finance UKYahoo Finance UK · Sat, 01 Aug 2026 02:35:08 GMT